Literature DB >> 24432242

Chromoblastomycosis caused by Rhinocladiella aquaspersa.

Gloria M González1, O Carolina Rojas1, José G González2, Yingqian Kang3, G S de Hoog4.   

Abstract

A case of chromoblastomycosis of the hand caused by Rhinocladiella aquaspersa is described. The case was acquired locally in tropical Venezuela and was successfully treated with oral itraconazole.

Entities:  

Keywords:  Chromoblastomycosis; Itraconazole; Rhinocladiella aquaspersa

Year:  2013        PMID: 24432242      PMCID: PMC3885939          DOI: 10.1016/j.mmcr.2013.08.001

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN: 2211-7539


Introduction

Chromoblastomycosis is a chronic granulomatous fungal infection that causes hyperproliferation of cutaneous and subcutaneous tissues and is histologically characterized by the presence of muriform cells. Infection originates after the etiologic agent gains entrance via percutaneous trauma [1]. Main agents responsible for its etiology are Fonsecaea pedrosoi, Fonsecaea monophora, Cladophialophora carrionii, Phialophora verrucosa, and Rhinocladiella aquaspersa. The disease is found in tropical and subtropical areas [2-4], with the vicarious agents [5] of Fonsecaea and Phialophora occurring under hot and humid conditions [6], and Cladophialophora being restricted to arid climates [7-10]. R. aquaspersa is an uncommon cause of chromoblastomycosis, with most cases having been reported from the American continent [11-14]. The present paper presents a further case from Venezuela and summarizes the climatic conditions of the areas where R. aquaspersa is endemic.

Case report

A 63-year-old male construction worker, native and resident of a rural area in Siquisique (Caserío La Unión), Lara State, Venezuela, presented with an asymptomatic, localized lesion affecting the dorsal surface of the left hand, involving the knuckles and proximal interphalangeal joints of the third and fourth fingers. The dermatosis produced retraction of the fifth finger. Examination of the skin disclosed a scaly, crusted, dull-red plaque, friable with hemorrhagic dots. The lesion was almost flat and eroded. According to the patient, the lesion had developed over an 18-month period and trauma or inoculation was not recalled. There were no lymphatic commitments. He has never been outside Siquisique city. The patient denied other problems but was in poor health and nutritional conditions. To recover the etiologic agent, the area was soaked with alcohol and scrapings from the lesions were collected into a Petri dish using a sterile scalpel blade. Direct KOH examination of the crusts of the lesions revealed numerous thick-walled, globose or ovoidal, dark-brown muriform cells approximately 6−8 µm in diameter, either singly or arranged in groups. Microscopic examination of a biopsy specimen from the lesion stained with periodic acid Schiff showed pseudoepitheliomatous hyperplasia and a mixed cell granulomatous infiltrate consisted of lymphocytes, histiocytes, giant cells, and neutrophils. Muriform cells were observed in the granulomatous tissue. These results confirmed the clinical diagnosis of chromoblastomycosis (Fig. 1). There were no budding cells, hyphal elements, swollen cells, pseudohyphal elements, or moniliform hyphae.
Fig. 1

Histopathology examination showing cluster of muriform cells stained with periodic acid Schiff.

Cultures of skin scrapings were performed on Sabouraud's glucose agar (SGA) with chloramphenicol (0.5 mg/ml). After incubation at 30 °C a slow-growing dark mold was recovered. Microscopically scarce conidia were observed which did not allow identification of the fungus. The isolate was submitted to the Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico, for morphological and molecular identification. The patient was treated with oral itraconazole (100 mg/day).The lesions improved after 2 months, with significant healing, desquamations having disappeared, and culture became negative. No side effects were noted by the patient during the course of treatment. Unfortunately, the patient could not be contacted for further follow-up.

Mycology

The mold was subcultured on SGA and on potato dextrose agar (PDA) on culture plates (20 mm diam.) incubated at 30 °C. After 2 weeks velvety colonies developed which were dark olive with an olivaceous black reverses. Slide cultures were performed on PDA blocks. After 2 weeks slides were stained with lactophenol cotton blue and evaluated in a Nikon Eclipse 50i microscope fitted with a Nikon digital sight DS-2Mv camera. Microscopically brown, septate hyphae were observed. Conidiophores were erect, 70−90 µm long, unbranched, thick-walled and darkly pigmented, bearing conidia at their distal portions. Scars were noticed on the conidiophores at the sites where conidia had been implanted. Conidia were single-celled, smooth, ellipsoidal to clavate, 4.0−6.6 µm long, light brown. The mold was tentatively identified by morphology as a Rhinocladiella species. Carbohydrate assimilation was tested using API 20C AUX galleries (bioMérieux, Mexico) [15]. Hydrolysis of urea was tested using Christensen´s urea agar. Inoculated tubes were incubated at 30 °C for 10 days. Cycloheximide tolerance was investigated on commercial Mycosel agar. Plates were incubated at 30 °C for 10 days. Proteolytic activity was evaluated in gelatin agar slants after 20 days at 30 °C [16]. Thermotolerance was explored with strains incubated on PDA and Mycosel agar for 2 weeks at 30, 37, and 40 °C [17]. Salt tolerance was investigated in 2% malt extract agar with 5%, 10%, 17%, and 20% sodium chloride [18]. Plates were incubated at 30 °C for 20 days. The isolate assimilated d-glucose, glycerol, 2-k-d-gluconate, L-arabinose, d-xylose, adonitol, d-galactose, inositol, d-sorbitol, methyl-d-glucopiranoside, N-acetyl-glucosamine, d-cellobiose, d-maltose, d-saccharose, d-trehalose, d-melezitose, d-raffinose. In contrast, d-lactose and xylitol were not assimilated. Urea hydrolysis was positive, growth on Mycosel agar was not inhibited by cycloheximide, and liquefaction of gelatin was absent. The isolate grew at 30 °C, had limited growth at 37 °C, and failed to grow at 40 °C. Growth in malt extract agar with all sodium chloride concentrations tested was negative. For molecular identification, approximately 1 cm2 mycelium from 2-week-old cultures was transferred to 2 ml Eppendorf tubes containing 200 µl of enzymatic lyses buffer [20 mM Tris–HCl (pH 8), 2 mM EDTA, 1.2% Triton X-100, 20 mg/ml lysozyme], which were then incubated at 37 °C for 2 h with agitation. Afterwards, 390 µl TE 1× with 1% SDS and 4 µl (10 mg/ml) proteinase K were added and cells were incubated for 1 h at 55 °C. After, 100 µl 5 M NaCl and 80 µl of 10% CTAB/4.1% NaCl were added and the mixture was vortexed and incubated for 10 min at 65 °C. DNA was extracted twice with 1 vol of phenol–chloroform–isoamyl alcohol (25:24:1), precipitated with absolute ethanol, washed with 70% ethanol, air dried, and resuspended in 200 µl of Tris–EDTA buffer [19]. Ribosomal DNA ITS domains were amplified using primers ITS-4 (5′-TCCTCCGCTTATTGATATGC-3′) and ITS-5 (5′GGAAGTAAAAGTCGTAACAAGG-3′) [20]. Amplifications were performed in a final volume of 25 µl containing 1× PCR buffer, 2 mM MgCl2, 0.2 mM of each dNTP, 200 nM of each primer, 1 U of AmpliTaq polymerase (Bioline, Randolph, MA, U.S.A.) and 100 ng DNA. The thermocycling conditions were: 94 °C for 4 min, followed by 30 cycles of 94 °C for 60 s, 55 °C for 90 s, and 72 °C for 90 s, with final extension at 72 °C for 5 min. The final products were electrophoresed in 1.5% agarose gel and stained with ethidium bromide. Hyper Ladder I (Bioline) was used as a molecular weight marker for size determinations. The pattern of amplified bands was photographed and analyzed with the UVP Biolmaging System, EpiChemi III Darkroom. PCR products were purified using the commercial Wizard PCR Preps DNA purification system (Promega, Madison, WI, U.S.A.). Sequencing was performed in both directions at the Instituto de Biotecnología, Universidad Nacional Autónoma de México. DNA sequence fragments were compared to NCBI GenBank sequence entries using the BLAST algorithm and to a research database on black fungi at CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands. The sequence was deposited in GenBank with accession number GU177853 as species of order Chaetothyriales. Later, the isolate was identified at CBS as R. aquaspersa. The culture was deposited in the CBS reference collection as CBS 132913.

Antifungal susceptibility

Amphotericin B (AMB) (Bristol-Myers Squibb, Princeton, NJ, U.S.A.), itraconazole (ITZ) (Janssen Pharmaceutica, Beerse, Belgium), voriconazole (VRZ) (Pfizer, Inc., New York, NY, U.S.A.), posaconazole (PSZ) (Schering-Plough, Kenilworth,NJ, U.S.A.), and terbinafine (TBF) (Novartis, Mexico) were obtained in reagent-grade powder form from their respective manufacturers. Isolates were evaluated by using Clinical and Laboratory Standard Institute broth macrodilution approved standard reference method M38-A2 [21]. After adequate sporulation occurred on PDA, the mycelium was overlaid with sterile distilled water, and suspensions were made by softly scraping the colonies with wooden applicators. Heavy fragments were allowed to settle, and the upper, homogeneous supernatant was transferred to sterile tubes. Inocula suspension of 106 CFU/ml were prepared by hemacytometer counts and then diluted in RPMI 1640 medium with glutamine and morpholinopropanesulphonic acid buffer at a concentration of 0.165 M (Angus, Niagara Falls, NY, U.S.A.) to obtain a final organism concentration of 0.4−5×104 CFU/ml. The inoculum size for all tests was verified by plating 10 µl onto PDA, incubating the plates at 35 °C, and counting the number of colonies. Serial dilution of the drugs was made following the CLSI guidelines in order to obtain final concentrations of the drugs ranging from 0.015 to 8 mg/L for all antifungal compounds. Candida krusei ATCC 6258 and Paecilomyces variotii ATCC MYA3630 were used for quality control. Results of susceptibility testing were: AMB=2 µg/ml, TBF=0.06 µg/ml, ITZ=0.125 µg/ml, VRZ=1 µg/ml, and PSZ=0.25 µg/ml, respectively.

Discussion

R. aquaspersa is a rare agent of human chromoblastomycosis. An overview of clinical cases is presented in Table 1; several reports provided only very scant information. The majority of historical cases have not been verified by sequence data, but the morphology of R. aquaspersa is unmistakable. Most cases report the presence of muriform cells in tissue, but in Case 3 these were absent. The clinical appearance of the disease is highly diverse [23]. The main agents of the disease are classified in Cladophialophora and Fonsecaea and are restricted to arid and tropical climates, respectively [5,9], but environmental data of cases of R. aquaspersa do not show any consistency (Table 1). Caserío La Unión of the present case is located in the northernmost part of the state, between 600 and 700 m above mean sea level. This area presents temperatures between 23 and 28 °C, its annual precipitation varies between 950 and 1400 mm, and its annual evaporation rates range from 1400 to 2400 mm. The predominance of semi-deciduous vegetation is associated to the aforementioned climatic conditions. The global distribution of R. aquaspersa is (sub)tropical. The species has thus far not been recovered from the environment, but Badali et al. [14] mentioned a case acquired by from a cactus thorn suggesting a natural habitat on living or dead plants. Marques et al. [13] reported a case secondary to an insect bite.
Table 1

Published cases of Rhinocladiella aquaspersa.

CaseStrainPatient, ageSite, durationGeographyTherapyReference
1CBS 313.73No dataMexico[24]
2CBS 122635Male 56Hand, 15 yrAlpuyeca, Morelos, Mexico, 1000 m alt, aridTerbinafin 6 mo (500 mg/d), cured[14]
3FMR 7699Female 62Foot, cactus puncture, 20 yrSolanea, Paraiba, Brazil, 600 m alt, tropical dryElectrocauterization, itraconazole (200 mg/d), cured[14]
4Male 60Ear, 5 yrMedellin, Colombia, 1400 m alt, temperate dryItraconazole 7 mo (200 mg/d), cured[11]
5Female 52AbdomenSouth KoreaItraconazole 4 mo (200 mg/d), surgery; cured[25]
6Male 52Arm, leg, forehead, 2 y, insect biteMaranhão, Brazil, 300 m alt, tropicalKetoconazole; failure[13]
7Male 5Upper limb, 2 yrSanta Cruz de Bucaral, Falcon state, Venezuela, 800 m, aridItraconazole; failure[12]
8No dataMinas Gerais, Brazil, 300 m alt, tropical[26]
9No dataCosta Rica, tropical[12]
10CBS 132913Male 63Hand, 18 moSiquisique, Lara State, Venezuela, 600 m alt, tropicalItraconazole 2 mo (100 mg/day); curedPresent case
The species is susceptible to commonly used azoles, and in our case treatment of the infection with itraconazole led to healing within two months.

Conflict of interest statement

We declare that we have no conflict of interest.
  19 in total

1.  [Acrotheca aquaspersa nova, new species agent of chromomycosis].

Authors:  D Borelli
Journal:  Acta Cient Venez       Date:  1972

2.  Evaluation of proteolytic activity to differentiate some dematiaceous fungi.

Authors:  A Espinel-Ingroff; P R Goldson; M R McGinnis; T M Kerkering
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

3.  Forty years of chromoblastomycosis in Madagascar: a review.

Authors:  P Esterre; A Andriantsimahavandy; E R Ramarcel; J L Pecarrere
Journal:  Am J Trop Med Hyg       Date:  1996-07       Impact factor: 2.345

4.  Evaluation of the API 20C yeast identification system for the differentiation of some dematiaceous fungi.

Authors:  A Espinel-Ingroff; M R McGinnis; D H Pincus; P R Goldson; T M Kerkering
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

5.  Molecular ecology and pathogenic potential of Fonsecaea species.

Authors:  G S De Hoog; D Attili-Angelis; V A Vicente; A H G Gerrits Van Den Ende; F Queiroz-Telles
Journal:  Med Mycol       Date:  2004-10       Impact factor: 4.076

6.  Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis.

Authors:  H Badali; A Bonifaz; T Barrón-Tapia; D Vázquez-González; L Estrada-Aguilar; N M Cavalcante Oliveira; J F Sobral Filho; J Guarro; J F G M Meis; G S De Hoog
Journal:  Med Mycol       Date:  2010-08       Impact factor: 4.076

7.  Chromoblastomycosis caused by Rhinocladiella aquaspersa.

Authors:  S G Marques; C M Pedrozo Silva; M A Resende; L S Andreata; J M L Costa
Journal:  Med Mycol       Date:  2004-06       Impact factor: 4.076

8.  [Chromomycosis by Rhinocladiella aquaspera: The first case in Venezuela.].

Authors:  M Pérez-Blanco; G Fernández-Zeppenfeldt; R Hernández; F Yegres; D Borelli
Journal:  Rev Iberoam Micol       Date:  1998-03       Impact factor: 1.044

9.  Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa.

Authors:  M Arango; C Jaramillo; A Cortés; A Restrepo
Journal:  Med Mycol       Date:  1998-02       Impact factor: 4.076

Review 10.  Challenges in the therapy of chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Daniel Wagner de C L Santos
Journal:  Mycopathologia       Date:  2013-05-02       Impact factor: 2.574

View more
  10 in total

Review 1.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 2.  Black Molds and Melanized Yeasts Pathogenic to Humans.

Authors:  Anuradha Chowdhary; John Perfect; G Sybren de Hoog
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

3.  Fonsecaea pugnacius, a Novel Agent of Disseminated Chromoblastomycosis.

Authors:  Conceição M P S de Azevedo; Renata R Gomes; Vania A Vicente; Daniel W C L Santos; Sirlei G Marques; Mariana M F do Nascimento; Caroline E W Andrade; Raimunda R Silva; Flávio Queiroz-Telles; G Sybren de Hoog
Journal:  J Clin Microbiol       Date:  2015-06-17       Impact factor: 5.948

4.  Antifungal susceptibility of the endophytic fungus Rhinocladiella similis (URM 7800) isolated from the Caatinga dry forest in Brazil.

Authors:  Ana Patrícia Sousa Lopes de Pádua; Alessandra Koehler; Danielle Machado Pagani; Jadson Diogo Pereira Bezerra; Cristina Maria de Souza-Motta; Maria Lúcia Scroferneker
Journal:  Braz J Microbiol       Date:  2022-09-24       Impact factor: 2.214

5.  Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.

Authors:  Renata R Gomes; Vania A Vicente; Conceição M P S de Azevedo; Claudio G Salgado; Moises B da Silva; Flávio Queiroz-Telles; Sirlei G Marques; Daniel W C L Santos; Tania S de Andrade; Elizabeth H Takagi; Katia S Cruz; Gheniffer Fornari; Rosane C Hahn; Maria L Scroferneker; Rachel B Caligine; Mauricio Ramirez-Castrillon; Daniella P de Araújo; Daiane Heidrich; Arnaldo L Colombo; G S de Hoog
Journal:  PLoS Negl Trop Dis       Date:  2016-11-28

6.  Chromoblastomycosis caused by Rhinocladiella similis: Case report.

Authors:  Daiane Heidrich; Gloria M González; Danielle M Pagani; Mauricio Ramírez-Castrillón; Maria Lucia Scroferneker
Journal:  Med Mycol Case Rep       Date:  2017-04-07

7.  Global Spread of Human Chromoblastomycosis Is Driven by Recombinant Cladophialophora carrionii and Predominantly Clonal Fonsecaea Species.

Authors:  Shuwen Deng; Clement K M Tsui; A H G Gerrits van den Ende; Liyue Yang; Mohammad Javad Najafzadeh; Hamid Badali; Ruoyu Li; Ferry Hagen; Jacques F Meis; Jiufeng Sun; Somayeh Dolatabadi; Bernard Papierok; Weihua Pan; G S de Hoog; Wanqing Liao
Journal:  PLoS Negl Trop Dis       Date:  2015-10-23

8.  Environmental prospecting of black yeast-like agents of human disease using culture-independent methodology.

Authors:  Flávia de Fátima Costa; Nickolas Menezes da Silva; Morgana Ferreira Voidaleski; Vinicius Almir Weiss; Leandro Ferreira Moreno; Gabriela Xavier Schneider; Mohammad J Najafzadeh; Jiufeng Sun; Renata Rodrigues Gomes; Roberto Tadeu Raittz; Mauro Antonio Alves Castro; Graciela Bolzón Inez de Muniz; G Sybren de Hoog; Vania Aparecida Vicente
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

9.  A Model for Trans-Kingdom Pathogenicity in Fonsecaea Agents of Human Chromoblastomycosis.

Authors:  Gheniffer Fornari; Renata Rodrigues Gomes; Juliana Degenhardt-Goldbach; Suelen Silvana Dos Santos; Sandro Rogério de Almeida; Germana Davila Dos Santos; Marisol Dominguez Muro; Cleusa Bona; Rosana Herminia Scola; Edvaldo S Trindade; Israel Henrique Bini; Lisandra Santos Ferreira-Maba; Daiane Rigoni Kestring; Mariana Machado Fidelis do Nascimento; Bruna Jacomel Favoreto de Souza Lima; Morgana F Voidaleski; Douglas André Steinmacher; Bruna da Silva Soley; Shuwen Deng; Anamelia Lorenzetti Bocca; Moises B da Silva; Claudio G Salgado; Conceição Maria Pedroso E Silva de Azevedo; Vania Aparecida Vicente; Sybren de Hoog
Journal:  Front Microbiol       Date:  2018-10-09       Impact factor: 5.640

10.  Chromoblastomycosis caused by Rhinocladiella aquaspersa: first case report in Guatemala.

Authors:  Carlos Porras-López; María Guadalupe Frías-De-León; Roberto Arenas; Erick Martínez-Herrera
Journal:  An Bras Dermatol       Date:  2019-09-30       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.